BWX Technologies

BWXT · NYSE

$134.24−$1.59 (−1.17%)TodayMarket closed · Oct 20, 7:59 PM ET

Prev close $135.83

BWXT analyst rating

BuyConsensus of 12 analysts over the last 12 months. 75% rate it a buy.

Strong buy0
Buy9
Hold3
Underperform0
Sell0

12-month price target · 19 analysts

Average $218.37 (+62.7% upside)

Low: $166.65
Now: $134.24
High: $304.50

Upgrades and downgrades

The latest rating actions, newest first

BWXT analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Oct 13, 2026	Maintains	Overweight	$230.00 → $190.00	27%
Truist Securities	Oct 6, 2026	Maintains	Hold	$202.00 → $182.00	0%
Northland Capital Markets	Sep 30, 2026	Maintains	Outperform	$250.00 → $220.00	34%
B of A Securities	Sep 30, 2026	Maintains	Buy	$250.00 → $210.00	57%
Guggenheim	Sep 30, 2026	Maintains	Buy	$192.00	71%
BTIG	Sep 30, 2026	Maintains	Buy	$235.00	32%
BNP Paribas	Sep 24, 2026	Maintains	Neutral	$190.00 → $165.00	68%
Guggenheim	Sep 15, 2026	Initiates	Buy	$192.00	71%
Jefferies	Sep 3, 2026	Initiates	Buy	$181.00	57%
Wells Fargo	Aug 27, 2026	Upgrade	Underweight → Equal-Weight	$200.00 → $170.00	69%

The case for and against

Updated Oct 14, 2026

Bull case

BWX Technologies is well positioned to benefit from a generational U.S. nuclear build-out because it already has the manufacturing footprint, NRC licenses, and 70-plus years of operating experience needed to serve both government and commercial programs. Its Government Operations franchise offers unusual revenue visibility through sole-source naval nuclear work and long-cycle defense contracts, while Special Materials and advanced nuclear initiatives add incremental upside from programs such as HPDU, enrichment, and TRISO fuels. On the commercial side, revenue grew from about $330M in 2020 to over $1.1B in 2026E, supported by a $1.6B backlog and management’s 2030 targets of $5.5B-$6.0B revenue, $1.1B-$1.2B adjusted EBITDA, and $525M-$575M free cash flow.

Bear case

BWX Technologies is facing a valuation that appears stretched relative to its underlying earnings power, with the cited 24x 2026 EBITDA multiple implying expectations that may be difficult to justify if execution slips. The company’s reliance on Government Operations creates concentration risk, while the potential upside from enrichment, advanced fuels, domestic uranium production, and future AP1000 and SMR deployments remains largely forward-looking rather than yet fully reflected in operating results. Given the explicit downside risk of net income attributable to BWX Technologies turning negative, the stock’s premium valuation looks vulnerable if commercial nuclear growth or military program demand fails to offset weakness.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.